Clinical trials of disease-modifying agents in pediatric MSEmmanuelle Waubant, Rinze F. Neuteboom, Brenda Banwell et al.|Neurology|2019Cited by 77
High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot StudyGeorge Simeakis, Evangelos Terpos, Evangelia Zapanti et al.|Biomedicines|2023Cited by 5
High dose short term glucocorticoid (gc) treatment seems to have no long term negative effect on bone mineral density (bmd) of newly diagnosed multiple sclerosis (ms) patientsGeorge Simeakis, Evangelos Terpos, Katerina Saltiki et al.|Endocrine Abstracts|2021Cited by 0
Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient’s COVID-19 InfectionNikolaos Markoglou, Maria Anagnostouli, George Simeakis et al.|Biomedicines|2022Cited by 0